Last quarter (Q0 0), CytoDyn's total revenue was $―, a decrease of ― from the same quarter last year. In Q0, CytoDyn's net income was $-5.14M. See CytoDyn’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	May 24	May 23	May 22	May 21	May 20
Total Revenue	$ ―	$ ―	$ ―	$ 266.00K	$ ―	$ -404.34K
Cost of Revenue	$ ―	$ ―	$ 20.63M	$ 73.54M	$ 5.03M	$ ―
Gross Profit	$ ―	$ ―	$ -20.63M	$ -73.28M	$ -5.03M	$ -404.34K
Operating Expense	$ 14.93M	$ 19.71M	$ 22.14M	$ 75.17M	$ 93.18M	$ 77.63M
Operating Income	$ 8.68M	$ -18.06M	$ -40.58M	$ -145.40M	$ -104.60M	$ -74.65M
Net Non Operating Interest Income Expense	$ -1.35M	$ -4.66M	$ -4.62M	$ 61.56M	$ -49.90M	$ -22.93M
Other Income Expense	$ 8.80M	$ 13.37M	$ 8.80M	$ -3.85M	$ 23.92M	$ 32.48M
Pretax Income	$ -14.21M	$ -49.80M	$ -79.80M	$ -210.82M	$ -176.47M	$ -139.94M
Tax Provision	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Earnings From Equity Interest Net Of Tax	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Net Income Common Stockholders	$ -15.36M	$ -51.32M	$ -81.32M	$ -212.45M	$ -178.15M	$ -164.90M
Basic EPS	$ -0.01	$ -0.05	$ -0.10	$ -0.31	$ -0.27	$ ―
Diluted EPS	$ -0.01	$ -0.05	$ -0.10	$ -0.31	$ -0.27	$ ―
Basic Average Shares	$ 4.35B	$ 969.51M	$ 836.53M	$ 676.90M	$ 587.59M	$ 421.08M
Diluted Average Shares	$ 4.42B	$ 969.51M	$ 836.53M	$ 676.90M	$ ―	$ 421.08M
Dividend Per Share	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Total Operating Income As Reported	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Basic E P S	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Diluted E P S	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Rent Expense Supplemental	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Total Expenses	$ 14.93M	$ 19.71M	$ 42.77M	$ 145.67M	$ 98.20M	$ 77.63M
Net Income From Continuing And Discontinued Operation	$ -14.99M	$ -49.84M	$ -79.82M	$ -210.82M	$ -176.47M	$ -139.94M
Normalized Income	$ -8.33M	$ ―	$ ―	$ -166.55M	$ -119.41M	$ ―
Interest Expense	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
EBIT	$ -13.80M	$ -45.18M	$ -75.20M	$ -195.75M	$ -115.43M	$ -109.67M
EBITDA	$ -13.53M	$ -43.51M	$ -72.83M	$ -194.97M	$ -113.64M	$ -103.56M

Currency in USD

CytoDyn Earnings and Revenue History

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing